Last updated on October 2016

A study of rHIgM22 dosage in relapsing MS patients.


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple Sclerosis
  • Age: Between 18 - 70 Years
  • Gender: Male or Female

Eligibility criteria:

  • Ages Eligible for Study: 18 Years to 70 Years (Adult)
  • Genders Eligible for Study: Both
  • Diagnosed with MS
  • Present with a clinical acute relapse defined as a new or worsening neurological symptoms attributable to MS
  • Patient must be located within 60 miles of CNS study location.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.